Carregant...
A Descriptive Analysis of Transgender Participants in Phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru
BACKGROUND: HIV disproportionately impacts transgender populations globally, creating challenges to inclusion in trials requiring low HIV risk profiles (LHRP) for acquisition. Our knowledge of transgender individuals with LHRP is limited. We conducted an analysis of transgender and cisgender individ...
Guardat en:
| Publicat a: | Vaccine |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6699617/ https://ncbi.nlm.nih.gov/pubmed/31176538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.05.016 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|